Sign in to view content

Episode 4: 3-year Results of the TREX-AMD Trial with Dr. Charles Wykoff

Keyvan Koushan, MD, FRCSC

Audio
Published 2017

Related

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of >4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Updates from the Field
2019
Uveitis Training and the FAST Study with Dr. Nisha Acharya
Jayanth Sridhar, MD
Member Podcasts
2020
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: AMD-Neovascular

See more